David VanVliet

Interim Chief Executive Officer

David VanVliet

David VanVliet is Interim Chief Executive Officer for Pharma Tech Industries. He has assumed overall leadership of the company as industry veteran Tee Noland transitions to a new role as Pharma Tech’s Chairman of the Board.

David joins Pharma Tech Industries with more than 20 years of CEO and President-level experience spanning the healthcare and pharmaceutical sectors. Most recently, as President and CEO at Angelica, Inc. – a prominent supplier to thousands of hospitals, clinics and long-term care facilities – he successfully guided the company’s 4,000 employees and 26 production centers. David also has held leadership roles at notable companies including KV Pharmaceutical, Procter & Gamble, and Nabisco, Inc.

David graduated from Dartmouth College with a degree in economics and continued his graduate studies at George Washington University. He also has board experience at various public, private and non-profit organizations.